Confidence Nnenna Alaboson

Confidence Alaboson practices at Oncology Consultants, P. A. in Houston, Texas.

Confidence Alaboson's NPI, 1750954970, was assigned on July 24, 2021. Confidence Alaboson holds Texas license 1059151.

Confidence Alaboson's primary practice is Oncology Consultants, P. A., at 902 Frostwood Dr, Houston, TX 77024 in Harris County. The practice phone is (832) 333-1400.

Confidence Alaboson's primary practice is Oncology Consultants, P. A. in Houston, Texas. The medical group on file is Zangmeister Cancer Center. Dmand AI also links Confidence Alaboson to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Confidence Alaboson practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Confidence Alaboson's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Confidence Alaboson is licensed in Texas.

CMS counts 49 Medicare patients who saw Confidence Alaboson in 2024. The largest group is 65 to 74, with 19 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Confidence Alaboson's median patient age at 69, with 76% women.

In 2024, Confidence Alaboson wrote 289 Medicare Part D claims for 159 patients. 74% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Confidence Alaboson for performance year 2024, reported as part of a group. Confidence Alaboson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Confidence Alaboson as offering telehealth.

CMS Open Payments shows 55 general payments to Confidence Alaboson from 31 drug and device companies in 2025. Food and beverage make up the largest share, 84% of the total. Incyte Corporation paid the most, $220.